EXHIBIT 2 

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 1 of 17 PageID #: 2075
Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 2 of 17 PageID #: 2076
Patent Trial and Appeal Board

Fiscal Year 2023

PTAB Trial Statistics

FY23 End of Year Outcome Roundup

IPR, PGR

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 3 of 17 PageID #: 2077
IPR

1,209

98% PGR

30

2%

1,239

Total

Petitions filed by trial type 

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

Trial types include Inter Partes Review (IPR) and Post Grant Review (PGR).

3

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 4 of 17 PageID #: 2078
Electrical/Computer

861

69%

Mechanical & 

Business Method

248

20%

Chemical

34

3%

Bio/Pharma

91

7%

Design

5

0%

1,239

Total

Petitions filed by technology

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

4

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 5 of 17 PageID #: 2079
2 1 1 2 4 0 3 1 3 1 3 7 4

99 103

112 110 103 108

127

77 69

151

87 91

71

(30 PGRs in FY23)

(1,209 IPRs in FY23)

Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep

IPR

Petitions filed by month

(September 2023 and Prior 12 Months: Sept. 1, 2022 to Sept. 30, 2023)

PGR

5

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 6 of 17 PageID #: 2080
859

648 702 769 752

510 512 504 397 375

63%

56%

58%

66% 67%

FY19 FY20 FY21 FY22 FY23

Instituted

Denied

Institution rates by petition

(FY19 to FY23: Oct. 1, 2018 to Sept. 30, 2023)

by Petition

6

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 7 of 17 PageID #: 2081
667

567 645 661 648

290 320 338 296 259

70%

64% 66%

69%

71%

FY19 FY20 FY21 FY22 FY23

Instituted

Denied

Institution rates by patent

(FY19 to FY23: Oct. 1, 2018 to Sept. 30, 2023)

by Patent

7

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 8 of 17 PageID #: 2082
Institution rates by technology

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

Institution rate for each technology is calculated by dividing petitions instituted by 

decisions on institution (i.e., petitions instituted plus petitions denied). The outcomes 

of decisions on institution responsive to requests for rehearing are excluded.

66% (190 of 289)

70% (492 of 701)

50% (4 of 8)

49% (23 of 47)

52% (43 of 82)

Mechanical &

Business Method

Electrical/Computer

Design

Chemical

Bio/Pharma

8

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 9 of 17 PageID #: 2083
9

Settlements

(FY19 to FY23: Oct. 1, 2018 to Sept. 30, 2023)

Settlement rate is calculated by dividing total settlements by concluded proceedings in 

each fiscal year (i.e., denied institution, settled, dismissed, requested adverse judgment, 

and final written decision), excluding joined cases.

Settlement Rate

Settlements

PostInstitution

PreInstitution 259

163

273

174 189

243

146

192

165 213

31%

22%

32%

27%

30%

502

309

465

339

402

FY19 FY20 FY21 FY22 FY23

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 10 of 17 PageID #:

2084
10

Outcomes by petition

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

FWD patentability or unpatentability reported with respect to the claims at issue in the 

FWD. Joined cases are excluded.

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 11 of 17 PageID #:

2085
11

Outcomes by patent

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

FWD patentability or unpatentability reported with respect to the claims at issue in the 

FWD. “Mixed Outcome” is shown for patents receiving more than one type of outcome 

from the list of: denied, settled, dismissed, and/or req. adverse judgement only. A patent 

is listed in a FWD category if it ever received a FWD, regardless of other outcomes.

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 12 of 17 PageID #:

2086
12

Outcomes by claim challenged

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 13 of 17 PageID #:

2087
13

Claim outcomes

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

“No DI” and “No FWD” mean 

the claim was challenged but 

not addressed in a DI/FWD, e.g., 

due to settlement.

30% of challenged claims and 

51% of instituted claims were 

found unpatentable by a 

preponderance of the evidence.

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 14 of 17 PageID #:

2088
14

All patents: Fiscal Year 2023

(FY23: Oct. 1, 2022 to Sept. 30, 2023)

Events that end an AIA proceeding include final written decisions (FWD), settlements, 

dismissals, requests for adverse judgment, and denials of institution. A patent is listed in 

an FWD category if it ever received an FWD.

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 15 of 17 PageID #:

2089
15

All patents: All time

(All time: Sept. 16, 2012 to Sept. 30, 2023)

Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 16 of 17 PageID #:

2090
Case 2:23-cv-00103-JRG-RSP Document 70-2 Filed 01/25/24 Page 17 of 17 PageID #:

2091